ACUT
Price
$0.98
Change
+$0.09 (+10.11%)
Updated
Jun 27 closing price
Capitalization
15.75M
LGVN
Price
$1.32
Change
+$0.02 (+1.54%)
Updated
Jun 27 closing price
Capitalization
19.81M
Interact to see
Advertisement

ACUT vs LGVN

Header iconACUT vs LGVN Comparison
Open Charts ACUT vs LGVNBanner chart's image
Accustem Sciences
Price$0.98
Change+$0.09 (+10.11%)
Volume$459
Capitalization15.75M
Longeveron
Price$1.32
Change+$0.02 (+1.54%)
Volume$219.76K
Capitalization19.81M
ACUT vs LGVN Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. LGVN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Hold and LGVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ACUT: $0.98 vs. LGVN: $1.32)
Brand notoriety: ACUT and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 15% vs. LGVN: 178%
Market capitalization -- ACUT: $15.75M vs. LGVN: $19.81M
ACUT [@Biotechnology] is valued at $15.75M. LGVN’s [@Biotechnology] market capitalization is $19.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, ACUT is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 6 bullish TA indicator(s).

  • ACUT’s TA Score: 5 bullish, 3 bearish.
  • LGVN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than ACUT.

Price Growth

ACUT (@Biotechnology) experienced а +8.77% price change this week, while LGVN (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGVN($19.8M) has a higher market cap than ACUT($15.8M). ACUT YTD gains are higher at: 118.750 vs. LGVN (-23.699). ACUT has higher annual earnings (EBITDA): -1.42M vs. LGVN (-16.49M). LGVN has more cash in the bank: 14.3M vs. ACUT (36.4K). ACUT has less debt than LGVN: ACUT (57.6K) vs LGVN (1.3M). LGVN has higher revenues than ACUT: LGVN (2.23M) vs ACUT (0).
ACUTLGVNACUT / LGVN
Capitalization15.8M19.8M80%
EBITDA-1.42M-16.49M9%
Gain YTD118.750-23.699-501%
P/E RatioN/AN/A-
Revenue02.23M-
Total Cash36.4K14.3M0%
Total Debt57.6K1.3M4%
TECHNICAL ANALYSIS
Technical Analysis
ACUTLGVN
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VCIGF4.000.38
+10.50%
Vitreous Glass Inc.
NCRBF30.00N/A
N/A
Nippon Carbon Co., Ltd.
NDGPY8.30N/A
N/A
Nine Dragons Paper Holdings Ltd.
BMYMP801.01N/A
N/A
Bristol-Myers Squibb Co.
SOMLY8.89-0.06
-0.67%
Secom Co., Ltd.

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and LGVN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
+10.61%
LGVN - ACUT
30%
Poorly correlated
+1.54%
OKYO - ACUT
28%
Poorly correlated
+1.44%
IGMS - ACUT
21%
Poorly correlated
N/A
APVO - ACUT
20%
Poorly correlated
-4.64%
VRNA - ACUT
20%
Poorly correlated
-0.61%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with BRTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then BRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
+1.54%
BRTX - LGVN
42%
Loosely correlated
-3.59%
QURE - LGVN
37%
Loosely correlated
-2.46%
SNGX - LGVN
35%
Loosely correlated
-0.73%
KZIA - LGVN
33%
Loosely correlated
N/A
ACUT - LGVN
30%
Poorly correlated
+10.61%
More